Massachusetts Financial Services
KYNB

Massachusetts Financial Services’s Kyntra Bio KYNB Stock Holding History

Massachusetts Financial Services’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-937
Closed -$63.3K – 851
2023
Q2 		$63.3K Sell
937
-17
-2% -$7.03K ﹤0.01% 822
2023
Q1 		$445K Buy
+954
New +$505K ﹤0.01% 810
2022
Q4 		– Sell
-3,433
Closed -$1.12M – 861
2022
Q3 		$1.12M Buy
+3,433
New +$1.11M ﹤0.01% 774

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services's KYNB Position: Q3 2023 in Review

Massachusetts Financial Services sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 937 shares — an estimated $63.3K sold.

Massachusetts Financial Services first reported a position in KYNB in Q3 2022 and held it in 3 quarters. The position peaked at $1.12M in Q3 2022. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • Massachusetts Financial Services reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • Massachusetts Financial Services sold 937 Kyntra Bio shares in Q3 2023, an estimated $63.3K.
  • Massachusetts Financial Services first reported a position in Kyntra Bio in Q3 2022 and held it in 3 quarters.
  • Massachusetts Financial Services's Kyntra Bio position peaked at $1.12M in Q3 2022.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Massachusetts Financial Services's 13F filing for Q3 2023, filed 8 Nov 2023.